Annual report pursuant to Section 13 and 15(d)

Segment Information - Summary of Reportable Segments (Detail)

v3.23.1
Segment Information - Summary of Reportable Segments (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]    
Revenues $ 163,213 $ 203,018
Gross profit (loss) 74,432 109,528
Depreciation and amortization 29,095 28,927
(Recoveries), write-downs and other charges, net (846) 47
Impairment loss 30,551 7,367
Net (loss) income (449,391) (77,490)
Purchase of property, plant and equipment 6,939 19,440
Purchase of intangibles assets 113 959
Assets 303,467 344,989
Eastern Region    
Segment Reporting Information [Line Items]    
Revenues 96,478 128,979
Gross profit (loss) 52,108 83,108
Depreciation and amortization 16,743 16,885
(Recoveries), write-downs and other charges, net (620) 95
Impairment loss 695 127
Net (loss) income (4,981) 7,886
Purchase of property, plant and equipment 5,954 17,384
Purchase of intangibles assets 0 100
Assets 226,458 222,350
Western Region    
Segment Reporting Information [Line Items]    
Revenues 65,644 72,424
Gross profit (loss) 21,910 27,877
Depreciation and amortization 11,820 11,235
(Recoveries), write-downs and other charges, net 0  
Impairment loss 29,856 0
Net (loss) income (38,019) (2,792)
Purchase of property, plant and equipment 982 2,024
Assets 60,896 106,485
Other    
Segment Reporting Information [Line Items]    
Revenues [1] 1,091 1,615
Gross profit (loss) 414 (1,457)
Depreciation and amortization 532 807
(Recoveries), write-downs and other charges, net (226) (48)
Impairment loss 0 7,240
Net (loss) income (406,391) (82,584)
Purchase of property, plant and equipment 3 32
Purchase of intangibles assets 113 859
Assets $ 16,113 $ 16,154
[1] Revenues from segments below the quantitative thresholds are attributable to an operating segment of the Company that includes revenue from the sale of CBD products throughout the United States. This segment has never met any of the quantitative thresholds for determining reportable segments nor does it meet the qualitative criteria for aggregation with the Company’s reportable segments.